Barbara J. Coffey: Clinical Trials

1 trial sponsored by Barbara J. Coffey, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1

Follow Barbara J. Coffey: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Proof-of-Concept Safety Study of CPP-109 (Vigabatrin) for Treatment Refractory Tourette's Disorder
vigabatrin - Tourette's Disorder
Phase 1 / Phase 2CompletedBarbara J. Coffey42012-07-012018-01-19

Conditions studied

Tourette Syndrome (1)

Interventions

Vigabatrin (1)

Countries

United States (1)

Top investigators

Jonathan D Brodie, PhD,MD (1)